focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.25
Bid: 42.50
Ask: 44.00
Change: -0.25 (-0.57%)
Spread: 1.50 (3.529%)
Open: 43.50
High: 43.50
Low: 42.50
Prev. Close: 43.50
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Cornish Metals Jumps 40% On AIM Debut

Tue, 16th Feb 2021 11:31

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Mercantile Ports & Logistics, up 84% at 0.70 pence, 12-month range 0.2p-1.04p. The Indian port and logistics facility developer says subsidiary Karanja Terminal & Logistics Private inks a contract with Rudra Marine Services, while another contract is signed with an unnamed "major" cement manufacturer for use of its facility.

----------

Cornish Metals, 9.88p, up 41% from initial public offering price of 7.0p. Miner began life as a listed company in London on Tuesday after raising GBP8.2 million in its IPO.

----------

Cloudcoco, up 30% at 1.49p, 12-month range 0.5p-2.17p. The IT services provider says earnings in its first quarter came in significantly ahead year-on-year despite the challenging economic environment. Looking ahead, the Warrington, England-based company outlines a positive outlook, noting a healthy sales pipeline which underpins progress made in its turnaround plan.

----------

Jangada Mines, up 28% at 10.30p, 12-month range 0.9p-11p. Miner says its Pitombeiras vanadium project in Brazil has very good potential for becoming a profitable mine following a positive preliminary economic assessment.

----------

Avacta Group, up 19% at 184.00p, 12-month range 12.62p-215.25p. The pre-clinical stage biotechnology company says its SARS-CoV-2 rapid antigen test can identify patients with an infectious viral load with no false positive results.

----------

AIM - LOSERS

----------

Rambler Metals & Mining, down 14% at 0.31p, 12-month range 0.2p-2.0p. Minerals explorer says it has raised USD10.5 million through the placing of 2.55 billion shares at 0.3p each. Will use the new cash to add equipment to its mining fleet to support operations upon a return to mill production capacity of 1,350 tonnes per day.

----------

Kodal Minerals, down 10% at 0.095p, 12-month range 0.02p-0.17p. The lithium-focussed development and exploration company says it has received a conversion notice in relation to its USD1.5 million unsecured convertible loan agreement with Riverfort Global Opportunities. Kodal notes it will convert USD169,385, made up of a principal amount of USD150,000 and accrued interest of USD19,385, into 153.4 million new shares at a price of 0.08p each.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
16 Mar 2022 13:02

Avacta offloads animal health unit in £2.3m deal

(Sharecast News) - Clinical-stage oncology drug company Avacta Group announced on Wednesday that Vimian Group has acquired its veterinary division, Avacta Animal Health, for consideration of up to £2.3m.

Read more
16 Mar 2022 11:38

Avacta sells veterinary division to Vimian for up to GBP2.3 million

(Alliance News) - Avacta Group PLC on Wednesday said it sold its veterinary division Avacta Animal Health to veterinary company Vimian Group AB.

Read more
3 Feb 2022 12:31

Avacta moves to next dose in first-in-human chemotherapy trial

(Sharecast News) - Clinical-stage oncology drug company Avacta announced on Thursday that the first-in-human phase 1 trial of 'AVA6000' pro-doxorubicin would advance to the next dose cohort, following a positive review of the safety data from the dosing of the first cohort.

Read more
3 Feb 2022 11:10

Avacta shares up 12% after chemotherapy drug advances to next stage

Avacta shares up 12% after chemotherapy drug advances to next stage

Read more
18 Jan 2022 14:36

Avacta Group selects second pro-drug candidate

(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group announced on Tuesday that the next 'preCISION' drug candidate, 'AVA3996', had been selected for preclinical development, with a view to a first-in-human phase one clinical trial from the second half of 2023.

Read more
18 Jan 2022 13:52

Avacta selects potential tumour treatment for preclinical development

Avacta selects potential tumour treatment for preclinical development

Read more
18 Jan 2022 10:58

AIM WINNERS & LOSERS: Sanderson Design lifts outlook, Gattaca lowers

AIM WINNERS & LOSERS: Sanderson Design lifts outlook, Gattaca lowers

Read more
10 Jan 2022 12:16

LONDON MARKET MIDDAY: Stocks slip as investors brace for Fed testimony

LONDON MARKET MIDDAY: Stocks slip as investors brace for Fed testimony

Read more
10 Jan 2022 12:08

Abingdon Health plunges after Avacta stops selling Covid-19 test

Abingdon Health plunges after Avacta stops selling Covid-19 test

Read more
10 Jan 2022 11:29

AIM WINNERS & LOSERS: Avacta sinks as halts sales of Covid-19 tests

AIM WINNERS & LOSERS: Avacta sinks as halts sales of Covid-19 tests

Read more
10 Jan 2022 11:05

Shares plummet as Avacta pauses sale of lateral flow tests

(Sharecast News) - Avacta Group has suspended sales of its antigen lateral flow tests, causing the AIM-listed firm's share price to plummet.

Read more
10 Jan 2022 09:20

Avacta shares drop as Covid tests show reduced sensitivity to Omicron

Avacta shares drop as Covid tests show reduced sensitivity to Omicron

Read more
22 Dec 2021 12:21

LONDON MARKET MIDDAY: Stocks edge higher ahead of US growth figures

LONDON MARKET MIDDAY: Stocks edge higher ahead of US growth figures

Read more
22 Dec 2021 11:28

AIM WINNERS & LOSERS: BlueRock hit by Covid; D4T4 up on contract wins

AIM WINNERS & LOSERS: BlueRock hit by Covid; D4T4 up on contract wins

Read more
22 Dec 2021 10:31

Avacta shares up as flow tests receive CE mark for self-test use

Avacta shares up as flow tests receive CE mark for self-test use

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.